User:Mchen2022/sandbox

Given the nature of this disease, chemo-resistance could occur and lead to disease relapse.

A recent systemic treatment review, it has anticipated that anti-PD1/PD-L1 checkpoint inhibitor would play a significant role in the management of relapsed GTN.

Reference:


 * 1) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7116872/